Latest filing published 05 Jan 2021 for Lexicon Pharmaceuticals, INC..
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +110.3%Entry US$5.95 · Close at T+365 US$12.51
- +110.3%Entry US$5.95 · Close at T+365 US$12.51
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
C.V. Invus: trading record in brief
All filings by C.V. Invus on record concern Lexicon Pharmaceuticals, Inc. In total, 4 filings cover trades dated from 23 October 2012 to 31 December 2020.
The open-market record is one-sided, with 3 purchases worth €5.5M and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
Half of the purchases are above €230k and half below.
Most recently, on 5 January 2021, the filings show a transaction in Lexicon Pharmaceuticals, Inc. The last purchase on record was published on 12 December 2014, which is 4,350 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to C.V. Invus
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,321,214 sharesCommon StockSEC:0000899243-21-000539:0
- 150,000 shares@ US$0.8802Common StockSEC:0001209191-14-075102:0Canonical exit: 12 Mar 2015 (T+90)
- 315,896 shares@ US$0.9033Common StockSEC:0001209191-14-074332:0Canonical exit: 10 Mar 2015 (T+90)
3 of 3 declarations